Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

BGJ398 for the Treatment of Tumor-Induced Osteomalacia

NCT03510455 is registered in ClinicalTrials.gov with National Institute of Dental and Craniofacial Research (NIDCR) as lead sponsor.

NCT NCT03510455
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03510455 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
BGJ398 for the Treatment of Tumor-Induced Osteomalacia
Lead sponsor
National Institute of Dental and Craniofacial Research (NIDCR)
Phase
Phase 2
Overall status
Terminated
Start date
February 27, 2019
Completion date
May 4, 2020
Enrollment
4 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

oncogenic osteomalacia, tumor-induced osteomalacia